NOTE: This product is an addon to ICMPro.
The ICMHomology modeling algorithm has proved to be one of the more robust modeling tools (16). After initial placement of the aligned
polypeptide chain onto the template structure, the sidechain torsion angles are predicted by simultaneous global optimization of the energy
for all nonidentical residues.
Methodology for conformational modeling of protein side chains and loops, implemented in ICM, relies on
internal coordinate definition of the molecular object combined with computationally efficient ICM Biased Probability Monte Carlo (BPMC)
optimization (7). An extended force field includes surface terms, electrostatics with the boundary element solution of the Poisson
equation (8), side chain entropy terms, and a fast algorithm for calculating molecular surfaces. The quality of the resulting 3D model is
assessed by a specialized ICM procedure, which also predicts possible backbone deviations between the homologues.
The ICM homology modeling
algorithm has demonstrated excellent accuracy in blind predictions at the CASP2 competition 6 and in several protein engineering
applications (916). Moreover, recent results show that ICM models built with as little as 35% identity can be accurate enough to be
successfully used in receptor based rational drug design (16,17).
Key features of ICMHomology include:
 Sensitive sequence search for template identification.
 Fast model building  the algorithm builds the model with all loops in seconds.
 Loop prediction using a loop PDB database.
 Loop prediction through local energy optimization.
 Multitemplate modeling.
 Loop grafting.
 Protein sculpting.
 Peptide modeling.
 Search the PDB for similar loop conformation.
 Calculate relative residue frequency in similar loops from the PDB.
 Prediction of Disulfide bonds.
 Local reliability prediction and model validation features.
 Model refinement using ICM global optimization.
 Membrane protein modeling.
 Highthroughput homology modeling.
References
(1) Schapira, M., B.M. Raaka, H.H. Samuels, andR. Abagyan. 2001. In Silico discovery of novel Retinoic Acid Receptor agonist structures. BMC Structural Biology 1:1.
(2) Schapira, M., R. Abagyan, andM. Totrov. 2002. Structural model of nicotinic acetylcholine receptor isotypes bound to acetylcholine and nicotine. BMC Struct Biol 2(1):1.
(3) Schapira, M., R. Abagyan, andM. Totrov. 2003. Nuclear hormone receptor targeted virtual screening. J Med Chem 46(14):30453059.
(4) Schapira, M., B.M. Raaka, S. Das, L. Fan, M. Totrov, Z. Zhou, S.R. Wilson, R. Abagyan, andH.H. Samuels. 2003. Discovery of diverse thyroid hormone receptor antagonists by highthroughput docking. Proc Natl Acad Sci U S A 100(12):73547359.
(5) Schapira, M., B.M. Raaka, H.H. Samuels, andR. Abagyan. 2000. Rational discovery of novel nuclear hormone receptor antagonists. Proc. Natl. Acad. Sci. U. S. A. 97(3):10081013.
(6) Abagyan, R., S. Batalov, T. Cardozo, M. Totrov, J. Webber, andY.Y. Zhou. 1997. Homology modeling with internal coordinate mechanics: Deformation zone mapping and improvements of models via conformational search. Proteins:2937.
(7) Abagyan, R.A., and M.M. Totrov. 1996. Biased probability Monte Carlo as a powerful global energy optimization method for biomolecular structure prediction. Abstr. Pap. Am. Chem. Soc. 211:35COMP.
(8) Totrov, M., andR. Abagyan. 2001. Rapid boundary element solvation electrostatics calculations in folding simulations: successful folding of a 23residue peptide. Biopolymers 60(2):124133.
(9) Borchert, T.V., R. Abagyan, R. Jaenicke, andR.K. Wierenga. 1994. Design, Creation, and Characterization of a Stable, Monomeric Triosephosphate Isomerase. Proc. Natl. Acad. Sci. U. S. A. 91(4):15151518.
(10) Borchert, T.V., K.V. Kishan, J.P. Zeelen, W. Schliebs, N. Thanki, R. Abagyan, R. Jaenicke, andR.K. Wierenga. 1995. Three new crystal structures of point mutation variants of monoTIM: conformational flexibility of loop1, loop4 and loop8. Structure 3(7):669679.
(11) Norledge, B.V., A.M. Lambeir, R.A. Abagyan, A. Rottmann, A.M. Fernandez, V.V. Filimonov, M.G. Peter, andR.K. Wierenga. 2001. Modeling, mutagenesis, and structural studies on the fully conserved phosphatebinding loop (loop 8) of triosephosphate isomerase: Toward a new substrate specificity. Proteins 42(3):383389.
(12) Thanki, N., J.P. Zeelen, M. Mathieu, R. Jaenicke, R.A. Abagyan, R.K. Wierenga, andW. Schliebs. 1997. Protein engineering with monomeric triosephosphate isomerase (monoTIM): the modelling and structure verification of a sevenresidue loop. Protein Eng 10(2):159167
(13) Cardozo, T., Totrov, M.M. & Abagyan, R.A (1995) Homology modeling by the ICM method. Proteins, 23, 403414.
(14) Rashin, A.A., Rashin, B.H., Rashin A., Abagyan, R. (1997) Evaluating the energetics of empty cavities and internal mutations in proteins. Protein Science, 6, 21432158.
(15) Norledge, B.V., Lambeir, A.M., Abagyan, R.A., Rottmann, A., Fernandez, A.M., Filimonov, V., Peter, M.G., and Wierenga, R.K. (2001). Modeling, mutagenesis, and structural studies on the fully conserved phosphateloop (loop 8) of triosephosphate isomerase: toward a new substrate specificity. Proteins Feb 15;42(3), 3839
(16) Cardozo, T.J., Abagyan, R. (1998) Molecular Modeling of the Domain Shared Between CED4 and its Mammalian Homologue Apaf1: A Structural Relationship to the Gproteins. J. Mol. Model., 4, 8393.
(17) Abagyan, R., andM. Totrov. 2001. Highthroughput docking for lead generation. Curr Opin Chem Biol 5(4):375382.
